Treating refractory advanced or metastatic urothelial carcinoma with interleukin-2: A phase II study

Jeri Kim, Randall E. Millikan, Terry L. Smith, Shi Ming Tu, Lance C. Pagliaro, Christopher J. Logothetis

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Treating refractory advanced or metastatic urothelial carcinoma with interleukin-2: A phase II study'. Together they form a unique fingerprint.

Medicine & Life Sciences